DrugCite
Search

WINRHO SDF

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Winrho Sdf Adverse Events Reported to the FDA Over Time

How are Winrho Sdf adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Winrho Sdf, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Winrho Sdf is flagged as the suspect drug causing the adverse event.

Most Common Winrho Sdf Adverse Events Reported to the FDA

What are the most common Winrho Sdf adverse events reported to the FDA?

Chills
160 (3.23%)
Haemoglobin Decreased
134 (2.7%)
Intravascular Haemolysis
131 (2.64%)
Haemolysis
126 (2.54%)
Pyrexia
116 (2.34%)
Back Pain
93 (1.88%)
Headache
89 (1.79%)
Nausea
71 (1.43%)
Haemolytic Anaemia
59 (1.19%)
Overdose
59 (1.19%)
Vomiting
55 (1.11%)
Show More Show More
Blood Lactate Dehydrogenase Increas...
54 (1.09%)
Renal Failure
51 (1.03%)
Renal Failure Acute
51 (1.03%)
Asthenia
50 (1.01%)
Disseminated Intravascular Coagulat...
50 (1.01%)
Dyspnoea
50 (1.01%)
Fatigue
50 (1.01%)
Chromaturia
49 (.99%)
Pain In Extremity
49 (.99%)
Anaemia
45 (.91%)
Blood Bilirubin Increased
44 (.89%)
Tremor
44 (.89%)
Hypotension
40 (.81%)
Platelet Count Decreased
40 (.81%)
Jaundice
39 (.79%)
Haemoglobinuria
37 (.75%)
Infusion Related Reaction
34 (.69%)
Pain
33 (.67%)
Blood Glucose Increased
31 (.63%)
Condition Aggravated
31 (.63%)
Abdominal Pain
30 (.6%)
Dizziness
30 (.6%)
Myalgia
30 (.6%)
Aspartate Aminotransferase Increase...
29 (.58%)
Diarrhoea
29 (.58%)
Dialysis
28 (.56%)
Tachycardia
26 (.52%)
Haematuria
25 (.5%)
Chest Pain
24 (.48%)
Confusional State
24 (.48%)
Splenomegaly
24 (.48%)
Thrombocytopenia
22 (.44%)
Blood Pressure Increased
20 (.4%)
Cardio-respiratory Arrest
20 (.4%)
Drug Exposure During Pregnancy
20 (.4%)
Haptoglobin Decreased
20 (.4%)
Hypertension
20 (.4%)
Myocardial Infarction
20 (.4%)
Activated Partial Thromboplastin Ti...
19 (.38%)
Malaise
19 (.38%)
Muscle Spasms
19 (.38%)
Oxygen Saturation Decreased
19 (.38%)
White Blood Cell Count Increased
19 (.38%)
Drug Ineffective
18 (.36%)
Encephalopathy
18 (.36%)
Transfusion Reaction
18 (.36%)
Acute Respiratory Distress Syndrome
17 (.34%)
Arthralgia
17 (.34%)
Coombs Test Positive
17 (.34%)
Hypersensitivity
17 (.34%)
Idiopathic Thrombocytopenic Purpura
17 (.34%)
Lethargy
17 (.34%)
Lung Infiltration
17 (.34%)
Sinus Tachycardia
17 (.34%)
Somnolence
17 (.34%)
Abdominal Pain Upper
16 (.32%)
Blood Urine Present
16 (.32%)
Cardiomegaly
16 (.32%)
Coagulopathy
16 (.32%)
Hyperhidrosis
16 (.32%)
Respiratory Distress
16 (.32%)
Contusion
15 (.3%)
Coombs Direct Test Positive
15 (.3%)
Extravascular Haemolysis
15 (.3%)
Haemolytic Transfusion Reaction
15 (.3%)
Antibody Test Positive
14 (.28%)
Depressed Level Of Consciousness
14 (.28%)
Haemodialysis
14 (.28%)
Hepatic Failure
14 (.28%)
Influenza Like Illness
14 (.28%)
Liver Function Test Abnormal
14 (.28%)
Status Epilepticus
14 (.28%)
Alanine Aminotransferase Increased
13 (.26%)
Anxiety
13 (.26%)
Blood Alkaline Phosphatase Increase...
13 (.26%)
Blood Pressure Decreased
13 (.26%)
Blood Sodium Decreased
13 (.26%)
Fluid Overload
13 (.26%)
Flushing
13 (.26%)
Hyperbilirubinaemia
13 (.26%)
International Normalised Ratio Incr...
13 (.26%)
Respiratory Failure
13 (.26%)
Tachypnoea
13 (.26%)
Pulmonary Embolism
12 (.24%)
Ventricular Tachycardia
12 (.24%)
Acute Respiratory Failure
11 (.22%)
Agitation
11 (.22%)
Anaemia Haemolytic Autoimmune
11 (.22%)
Anaphylactic Reaction
11 (.22%)
Cardiac Arrest
11 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Winrho Sdf, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Winrho Sdf is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Winrho Sdf

What are the most common Winrho Sdf adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Winrho Sdf, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Winrho Sdf is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Winrho Sdf According to Those Reporting Adverse Events

Why are people taking Winrho Sdf, according to those reporting adverse events to the FDA?

Idiopathic Thrombocytopenic Purpura
386
Autoimmune Thrombocytopenia
21
Thrombocytopenia
17
Thrombocytopenic Purpura
10
Rhesus Haemolytic Disease Of Newbor...
7
Prophylaxis Against Rh Isoimmunisat...
6
Show More Show More
Foetal-maternal Haemorrhage
6
Prophylaxis
4
Isoimmune Haemolytic Disease
2
Platelet Count Decreased
2
Rhesus Incompatibility
2
Anaemia Haemolytic Autoimmune
1
Haemorrhage
1
Antiphospholipid Syndrome
1
Abortion Threatened
1
Purpura
1
Blood Product Transfusion
1
Dengue Fever
1

Drug Labels

LabelLabelerEffective
WinrhoCangene bioPharma Inc.11-JAN-11

Winrho Sdf Case Reports

What Winrho Sdf safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Winrho Sdf. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Winrho Sdf.